172 related articles for article (PubMed ID: 2194199)
1. Bile salt-fatty acid mixed micelles as nasal absorption promoters of peptides. II. In vivo nasal absorption of insulin in rats and effects of mixed micelles on the morphological integrity of the nasal mucosa.
Tengamnuay P; Mitra AK
Pharm Res; 1990 Apr; 7(4):370-5. PubMed ID: 2194199
[TBL] [Abstract][Full Text] [Related]
2. Bile salt-fatty acid mixed micelles as nasal absorption promoters of peptides. I. Effects of ionic strength, adjuvant composition, and lipid structure on the nasal absorption of [D-Arg2]kyotorphin.
Tengamnuay P; Mitra AK
Pharm Res; 1990 Feb; 7(2):127-33. PubMed ID: 2308892
[TBL] [Abstract][Full Text] [Related]
3. Bile salt-fatty acid mixed micelles as nasal absorption promoters. III. Effects on nasal transport and enzymatic degradation of acyclovir prodrugs.
Shao Z; Mitra AK
Pharm Res; 1994 Feb; 11(2):243-50. PubMed ID: 8165183
[TBL] [Abstract][Full Text] [Related]
4. Acyclovir permeation enhancement across intestinal and nasal mucosae by bile salt-acylcarnitine mixed micelles.
Park GB; Shao Z; Mitra AK
Pharm Res; 1992 Oct; 9(10):1262-7. PubMed ID: 1448423
[TBL] [Abstract][Full Text] [Related]
5. Nasal membrane and intracellular protein and enzyme release by bile salts and bile salt-fatty acid mixed micelles: correlation with facilitated drug transport.
Shao Z; Mitra AK
Pharm Res; 1992 Sep; 9(9):1184-9. PubMed ID: 1409402
[TBL] [Abstract][Full Text] [Related]
6. Aminated gelatin as a nasal absorption enhancer for peptide drugs: evaluation of absorption enhancing effect and nasal mucosa perturbation in rats.
Wang J; Sakai S; Deguchi Y; Bi D; Tabata Y; Morimoto K
J Pharm Pharmacol; 2002 Feb; 54(2):181-8. PubMed ID: 11848281
[TBL] [Abstract][Full Text] [Related]
7. Chitosan as a novel nasal delivery system for peptide drugs.
Illum L; Farraj NF; Davis SS
Pharm Res; 1994 Aug; 11(8):1186-9. PubMed ID: 7971722
[TBL] [Abstract][Full Text] [Related]
8. Mutual inhibition of the insulin absorption-enhancing properties of dodecylmaltoside and dimethyl-beta-cyclodextrin following nasal administration.
Ahsan F; Arnold JJ; Meezan E; Pillion DJ
Pharm Res; 2001 May; 18(5):608-14. PubMed ID: 11465415
[TBL] [Abstract][Full Text] [Related]
9. Reestablishment of the nasal permeability barrier to several peptides following exposure to the absorption enhancer tetradecyl-beta-D-maltoside.
Arnold JJ; Fyrberg MD; Meezan E; Pillion DJ
J Pharm Sci; 2010 Apr; 99(4):1912-20. PubMed ID: 19894270
[TBL] [Abstract][Full Text] [Related]
10. Promotion of nasal absorption of insulin by glycyrrhetinic acid derivatives. I.
Mishima M; Okada S; Wakita Y; Nakano M
J Pharmacobiodyn; 1989 Jan; 12(1):31-6. PubMed ID: 2656985
[TBL] [Abstract][Full Text] [Related]
11. Chitosans as nasal absorption enhancers of peptides: comparison between free amine chitosans and soluble salts.
Tengamnuay P; Sahamethapat A; Sailasuta A; Mitra AK
Int J Pharm; 2000 Mar; 197(1-2):53-67. PubMed ID: 10704793
[TBL] [Abstract][Full Text] [Related]
12. Nasal absorption of insulin: enhancement by hydrophobic bile salts.
Gordon GS; Moses AC; Silver RD; Flier JS; Carey MC
Proc Natl Acad Sci U S A; 1985 Nov; 82(21):7419-23. PubMed ID: 3903753
[TBL] [Abstract][Full Text] [Related]
13. Effect of cell-penetrating peptides on the nasal absorption of insulin.
Khafagy el-S; Morishita M; Isowa K; Imai J; Takayama K
J Control Release; 2009 Jan; 133(2):103-8. PubMed ID: 18930084
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of nasal absorption of insulin using chitosan nanoparticles.
Fernández-Urrusuno R; Calvo P; Remuñán-López C; Vila-Jato JL; Alonso MJ
Pharm Res; 1999 Oct; 16(10):1576-81. PubMed ID: 10554100
[TBL] [Abstract][Full Text] [Related]
15. Quantitative estimation of the effects of bile salt surfactant systems on insulin stability and permeability in the rat intestine using a mass balance model.
Lane ME; O'driscoll CM; Corrigan OI
J Pharm Pharmacol; 2005 Feb; 57(2):169-75. PubMed ID: 15720779
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of intestinal insulin absorption by bile salt-fatty acid mixed micelles in dogs.
Scott-Moncrieff JC; Shao Z; Mitra AK
J Pharm Sci; 1994 Oct; 83(10):1465-9. PubMed ID: 7884671
[TBL] [Abstract][Full Text] [Related]
17. Aminated gelatin microspheres as a nasal delivery system for peptide drugs: evaluation of in vitro release and in vivo insulin absorption in rats.
Wang J; Tabata Y; Morimoto K
J Control Release; 2006 Jun; 113(1):31-7. PubMed ID: 16707188
[TBL] [Abstract][Full Text] [Related]
18. Isolation, characterization and study of enhancing effects on nasal absorption of insulin in rat of the total saponin from Acanthophyllum squarrosum.
Sajadi Tabassi SA; Hosseinzadeh H; Ramezani M; Moghimipour E; Mohajeri SA
Curr Drug Deliv; 2006 Oct; 3(4):399-404. PubMed ID: 17076642
[TBL] [Abstract][Full Text] [Related]
19. Nasal absorption and local tissue reaction of insulin nanocomplexes of trimethyl chitosan derivatives in rats.
Jintapattanakit A; Peungvicha P; Sailasuta A; Kissel T; Junyaprasert VB
J Pharm Pharmacol; 2010 May; 62(5):583-91. PubMed ID: 20609059
[TBL] [Abstract][Full Text] [Related]
20. Nasal absorption in the rat. III. Effect of lysophospholipids on insulin absorption and nasal histology.
Chandler SG; Thomas NW; Illum L
Pharm Res; 1994 Nov; 11(11):1623-30. PubMed ID: 7870681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
